Diversity in immunogenomics: the value and the challenge
Authors:
Kerui Peng,
Yana Safonova,
Mikhail Shugay,
Alice Popejoy,
Oscar Rodriguez,
Felix Breden,
Petter Brodin,
Amanda M. Burkhardt,
Carlos Bustamante,
Van-Mai Cao-Lormeau,
Martin M. Corcoran,
Darragh Duffy,
Macarena Fuentes Guajardo,
Ricardo Fujita,
Victor Greiff,
Vanessa D. Jonsson,
Xiao Liu,
Lluis Quintana-Murci,
Maura Rossetti,
Jianming Xie,
Gur Yaari,
Wei Zhang,
Malak S. Abedalthagafi,
Khalid O. Adekoya,
Rahaman A. Ahmed
, et al. (10 additional authors not shown)
Abstract:
With the advent of high-throughput sequencing technologies, the fields of immunogenomics and adaptive immune receptor repertoire research are facing both opportunities and challenges. Adaptive immune receptor repertoire sequencing (AIRR-seq) has become an increasingly important tool to characterize T and B cell responses in settings of interest. However, the majority of AIRR-seq studies conducted…
▽ More
With the advent of high-throughput sequencing technologies, the fields of immunogenomics and adaptive immune receptor repertoire research are facing both opportunities and challenges. Adaptive immune receptor repertoire sequencing (AIRR-seq) has become an increasingly important tool to characterize T and B cell responses in settings of interest. However, the majority of AIRR-seq studies conducted so far were performed in individuals of European ancestry, restricting the ability to identify variation in human adaptive immune responses across populations and limiting their applications. As AIRR-seq studies depend on the ability to assign VDJ sequence reads to the correct germline gene segments, efforts to characterize the genomic loci that encode adaptive immune receptor genes in different populations are urgently needed. The availability of comprehensive germline gene databases and further applications of AIRR-seq studies to individuals of non-European ancestry will substantially enhance our understanding of human adaptive immune responses, promote the development of effective diagnostics and treatments, and eventually advance precision medicine.
△ Less
Submitted 1 March, 2021; v1 submitted 20 October, 2020;
originally announced October 2020.
Detecting T-cell receptors involved in immune responses from single repertoire snapshots
Authors:
Mikhail V Pogorelyy,
Anastasia A Minervina,
Mikhail Shugay,
Dmitriy M Chudakov,
Yuri B Lebedev,
Thierry Mora,
Aleksandra M Walczak
Abstract:
Hypervariable T-cell receptors (TCR) play a key role in adaptive immunity, recognising a vast diversity of pathogen-derived antigens. High throughput sequencing of TCR repertoires (RepSeq) produces huge datasets of T-cell receptor sequences from blood and tissue samples. However, our ability to extract clinically relevant information from RepSeq data is limited, mainly because little is known abou…
▽ More
Hypervariable T-cell receptors (TCR) play a key role in adaptive immunity, recognising a vast diversity of pathogen-derived antigens. High throughput sequencing of TCR repertoires (RepSeq) produces huge datasets of T-cell receptor sequences from blood and tissue samples. However, our ability to extract clinically relevant information from RepSeq data is limited, mainly because little is known about TCR-disease associations. Here we present a statistical approach called ALICE (Antigen-specific Lymphocyte Identification by Clustering of Expanded sequences) that identifies TCR sequences that are actively involved in the current immune response from a single RepSeq sample, and apply it to repertoires of patients with a variety of disorders - autoimmune disease (ankylosing spondylitis), patients under cancer immunotherapy, or subject to an acute infection (live yellow fever vaccine). The method's robustness is demonstrated by the agreement of its predictions with independent assays, and is supported by its ability to selectively detect responding TCR in the memory but not in the naive subset. ALICE requires no longitudinal data collection nor large cohorts, and is thus directly applicable to most RepSeq datasets. Its results facilitate the identification of TCR variants associated with a wide variety of diseases and conditions, which can be used for diagnostics, rational vaccine design and evaluation of the adaptive immune system state.
△ Less
Submitted 23 July, 2018;
originally announced July 2018.
